INN: Tranexamic acid
250 mg, 500 mg film-coated tablets No. 10, No. 30
Included in EDL
MA number: LP-006449
By prescription
hemostatic agent - fibrinolysis inhibitor
Short-term treatment of bleeding connected with increased fibrinolysis in the following pathological conditions:
- prostatectomy;
- surgical interventions on the bladder;
- menorrhagia;
- nose bleed;
- conization of the cervix;
- traumatic hyphema (bleeding in the anterior eye chamber).
Hereditary angioedema (prevention of exacerbations of the disease).
Bleeding during pregnancy.